▶ 調査レポート

世界の風邪・インフルエンザ薬市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Cold and Flu Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の風邪・インフルエンザ薬市場 2021:企業別、地域別、種類・用途別 / Global Cold and Flu Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-2104Z03365資料のイメージです。• レポートコード:GIR-2104Z03365
• 出版社/出版日:GlobalInfoResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療・医薬品
• 販売価格(消費税別)
  Single User¥504,600 (USD3,480)▷ お問い合わせ
  Multi User¥756,900 (USD5,220)▷ お問い合わせ
  Corporate User¥1,009,200 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、風邪・インフルエンザ薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。風邪・インフルエンザ薬の種類別市場規模(抗ヒスタミン薬、去痰薬、気管支拡張薬、充血除去薬、抗生物質、その他)、用途別市場規模(OTC、Rx)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・風邪・インフルエンザ薬の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Reckitt Benckiser Group、Johnson & Johnson、GlaxoSmithKline、Novartis、Bayer、AstraZeneca、Sun Pharmaceutical Industries、Pfizer、Prestige Brands Holdings、Procter & Gamble
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:抗ヒスタミン薬、去痰薬、気管支拡張薬、充血除去薬、抗生物質、その他
・用途別分析2016年-2026年:OTC、Rx
・風邪・インフルエンザ薬の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・風邪・インフルエンザ薬のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・風邪・インフルエンザ薬のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・風邪・インフルエンザ薬の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・風邪・インフルエンザ薬の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Cold and Flu Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Cold and Flu Drugs size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Cold and Flu Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Cold and Flu Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Others

Market segment by Application, can be divided into
OTC
Rx

Market segment by players, this report covers
Reckitt Benckiser Group
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
AstraZeneca
Sun Pharmaceutical Industries
Pfizer
Prestige Brands Holdings
Procter & Gamble

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Cold and Flu Drugs
1.2 Classification of Cold and Flu Drugs by Type
1.2.1 Overview: Global Cold and Flu Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Cold and Flu Drugs Revenue Market Share by Type in 2020
1.2.3 Antihistamines
1.2.4 Expectorants
1.2.5 Bronchodilators
1.2.6 Decongestants
1.2.7 Antibiotics
1.2.8 Others
1.3 Global Cold and Flu Drugs Market by Application
1.3.1 Overview: Global Cold and Flu Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 OTC
1.3.3 Rx
1.4 Global Cold and Flu Drugs Market Size & Forecast
1.5 Global Cold and Flu Drugs Market Size and Forecast by Region
1.5.1 Global Cold and Flu Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Cold and Flu Drugs Market Size by Region, (2016-2021)
1.5.3 North America Cold and Flu Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Cold and Flu Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Cold and Flu Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Cold and Flu Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Cold and Flu Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cold and Flu Drugs Market Drivers
1.6.2 Cold and Flu Drugs Market Restraints
1.6.3 Cold and Flu Drugs Trends Analysis
2 Company Profiles
2.1 Reckitt Benckiser Group
2.1.1 Reckitt Benckiser Group Details
2.1.2 Reckitt Benckiser Group Major Business
2.1.3 Reckitt Benckiser Group Cold and Flu Drugs Product and Solutions
2.1.4 Reckitt Benckiser Group Cold and Flu Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Reckitt Benckiser Group Recent Developments and Future Plans
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Cold and Flu Drugs Product and Solutions
2.2.4 Johnson & Johnson Cold and Flu Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Cold and Flu Drugs Product and Solutions
2.3.4 GlaxoSmithKline Cold and Flu Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GlaxoSmithKline Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Cold and Flu Drugs Product and Solutions
2.4.4 Novartis Cold and Flu Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Novartis Recent Developments and Future Plans
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Cold and Flu Drugs Product and Solutions
2.5.4 Bayer Cold and Flu Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Bayer Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Cold and Flu Drugs Product and Solutions
2.6.4 AstraZeneca Cold and Flu Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 Sun Pharmaceutical Industries
2.7.1 Sun Pharmaceutical Industries Details
2.7.2 Sun Pharmaceutical Industries Major Business
2.7.3 Sun Pharmaceutical Industries Cold and Flu Drugs Product and Solutions
2.7.4 Sun Pharmaceutical Industries Cold and Flu Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Sun Pharmaceutical Industries Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Cold and Flu Drugs Product and Solutions
2.8.4 Pfizer Cold and Flu Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Prestige Brands Holdings
2.9.1 Prestige Brands Holdings Details
2.9.2 Prestige Brands Holdings Major Business
2.9.3 Prestige Brands Holdings Cold and Flu Drugs Product and Solutions
2.9.4 Prestige Brands Holdings Cold and Flu Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Prestige Brands Holdings Recent Developments and Future Plans
2.10 Procter & Gamble
2.10.1 Procter & Gamble Details
2.10.2 Procter & Gamble Major Business
2.10.3 Procter & Gamble Cold and Flu Drugs Product and Solutions
2.10.4 Procter & Gamble Cold and Flu Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Procter & Gamble Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cold and Flu Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Cold and Flu Drugs Players Market Share
3.2.2 Top 10 Cold and Flu Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Cold and Flu Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cold and Flu Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Cold and Flu Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Cold and Flu Drugs Revenue Market Share by Application (2016-2021)
5.2 Cold and Flu Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Cold and Flu Drugs Revenue by Type (2016-2026)
6.2 North America Cold and Flu Drugs Revenue by Application (2016-2026)
6.3 North America Cold and Flu Drugs Market Size by Country
6.3.1 North America Cold and Flu Drugs Revenue by Country (2016-2026)
6.3.2 United States Cold and Flu Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Cold and Flu Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Cold and Flu Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Cold and Flu Drugs Revenue by Type (2016-2026)
7.2 Europe Cold and Flu Drugs Revenue by Application (2016-2026)
7.3 Europe Cold and Flu Drugs Market Size by Country
7.3.1 Europe Cold and Flu Drugs Revenue by Country (2016-2026)
7.3.2 Germany Cold and Flu Drugs Market Size and Forecast (2016-2026)
7.3.3 France Cold and Flu Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Cold and Flu Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Cold and Flu Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Cold and Flu Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cold and Flu Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Cold and Flu Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Cold and Flu Drugs Market Size by Region
8.3.1 Asia-Pacific Cold and Flu Drugs Revenue by Region (2016-2026)
8.3.2 China Cold and Flu Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Cold and Flu Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Cold and Flu Drugs Market Size and Forecast (2016-2026)
8.3.5 India Cold and Flu Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Cold and Flu Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Cold and Flu Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Cold and Flu Drugs Revenue by Type (2016-2026)
9.2 South America Cold and Flu Drugs Revenue by Application (2016-2026)
9.3 South America Cold and Flu Drugs Market Size by Country
9.3.1 South America Cold and Flu Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Cold and Flu Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Cold and Flu Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cold and Flu Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Cold and Flu Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Cold and Flu Drugs Market Size by Country
10.3.1 Middle East & Africa Cold and Flu Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Cold and Flu Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Cold and Flu Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Cold and Flu Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Cold and Flu Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Cold and Flu Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Cold and Flu Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Cold and Flu Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Cold and Flu Drugs Revenue Market Share by Region (2021-2026)
Table 6. Reckitt Benckiser Group Corporate Information, Head Office, and Major Competitors
Table 7. Reckitt Benckiser Group Major Business
Table 8. Reckitt Benckiser Group Cold and Flu Drugs Product and Solutions
Table 9. Reckitt Benckiser Group Cold and Flu Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson Major Business
Table 12. Johnson & Johnson Cold and Flu Drugs Product and Solutions
Table 13. Johnson & Johnson Cold and Flu Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 15. GlaxoSmithKline Major Business
Table 16. GlaxoSmithKline Cold and Flu Drugs Product and Solutions
Table 17. GlaxoSmithKline Cold and Flu Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Novartis Corporate Information, Head Office, and Major Competitors
Table 19. Novartis Major Business
Table 20. Novartis Cold and Flu Drugs Product and Solutions
Table 21. Novartis Cold and Flu Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Bayer Corporate Information, Head Office, and Major Competitors
Table 23. Bayer Major Business
Table 24. Bayer Cold and Flu Drugs Product and Solutions
Table 25. Bayer Cold and Flu Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 27. AstraZeneca Major Business
Table 28. AstraZeneca Cold and Flu Drugs Product and Solutions
Table 29. AstraZeneca Cold and Flu Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Sun Pharmaceutical Industries Corporate Information, Head Office, and Major Competitors
Table 31. Sun Pharmaceutical Industries Major Business
Table 32. Sun Pharmaceutical Industries Cold and Flu Drugs Product and Solutions
Table 33. Sun Pharmaceutical Industries Cold and Flu Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Pfizer Corporate Information, Head Office, and Major Competitors
Table 35. Pfizer Major Business
Table 36. Pfizer Cold and Flu Drugs Product and Solutions
Table 37. Pfizer Cold and Flu Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Prestige Brands Holdings Corporate Information, Head Office, and Major Competitors
Table 39. Prestige Brands Holdings Major Business
Table 40. Prestige Brands Holdings Cold and Flu Drugs Product and Solutions
Table 41. Prestige Brands Holdings Cold and Flu Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Procter & Gamble Corporate Information, Head Office, and Major Competitors
Table 43. Procter & Gamble Major Business
Table 44. Procter & Gamble Cold and Flu Drugs Product and Solutions
Table 45. Procter & Gamble Cold and Flu Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Cold and Flu Drugs Revenue (USD Million) by Players (2019-2021)
Table 47. Global Cold and Flu Drugs Revenue Share by Players (2019-2021)
Table 48. Breakdown of Cold and Flu Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Cold and Flu Drugs Players Head Office, Products and Services Provided
Table 50. Cold and Flu Drugs Mergers & Acquisitions in the Past Five Years
Table 51. Cold and Flu Drugs New Entrants and Expansion Plans
Table 52. Global Cold and Flu Drugs Revenue (USD Million) by Type (2016-2021)
Table 53. Global Cold and Flu Drugs Revenue Share by Type (2016-2021)
Table 54. Global Cold and Flu Drugs Revenue Forecast by Type (2021-2026)
Table 55. Global Cold and Flu Drugs Revenue by Application (2016-2021)
Table 56. Global Cold and Flu Drugs Revenue Forecast by Application (2021-2026)
Table 57. North America Cold and Flu Drugs Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Cold and Flu Drugs Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Cold and Flu Drugs Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Cold and Flu Drugs Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Cold and Flu Drugs Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Cold and Flu Drugs Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Cold and Flu Drugs Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Cold and Flu Drugs Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Cold and Flu Drugs Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Cold and Flu Drugs Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Cold and Flu Drugs Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Cold and Flu Drugs Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Cold and Flu Drugs Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Cold and Flu Drugs Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Cold and Flu Drugs Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Cold and Flu Drugs Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Cold and Flu Drugs Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Cold and Flu Drugs Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Cold and Flu Drugs Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Cold and Flu Drugs Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Cold and Flu Drugs Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Cold and Flu Drugs Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Cold and Flu Drugs Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Cold and Flu Drugs Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Cold and Flu Drugs Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Cold and Flu Drugs Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Cold and Flu Drugs Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Cold and Flu Drugs Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Cold and Flu Drugs Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Cold and Flu Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Cold and Flu Drugs Picture
Figure 2. Global Cold and Flu Drugs Revenue Market Share by Type in 2020
Figure 3. Antihistamines
Figure 4. Expectorants
Figure 5. Bronchodilators
Figure 6. Decongestants
Figure 7. Antibiotics
Figure 8. Others
Figure 9. Cold and Flu Drugs Revenue Market Share by Application in 2020
Figure 10. OTC Picture
Figure 11. Rx Picture
Figure 12. Global Cold and Flu Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Cold and Flu Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Cold and Flu Drugs Revenue Market Share by Region (2016-2026)
Figure 15. Global Cold and Flu Drugs Revenue Market Share by Region in 2020
Figure 16. North America Cold and Flu Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Cold and Flu Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Cold and Flu Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Cold and Flu Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Cold and Flu Drugs Market Drivers
Figure 21. Cold and Flu Drugs Market Restraints
Figure 22. Cold and Flu Drugs Market Trends
Figure 23. Reckitt Benckiser Group Recent Developments and Future Plans
Figure 24. Johnson & Johnson Recent Developments and Future Plans
Figure 25. GlaxoSmithKline Recent Developments and Future Plans
Figure 26. Novartis Recent Developments and Future Plans
Figure 27. Bayer Recent Developments and Future Plans
Figure 28. AstraZeneca Recent Developments and Future Plans
Figure 29. Sun Pharmaceutical Industries Recent Developments and Future Plans
Figure 30. Pfizer Recent Developments and Future Plans
Figure 31. Prestige Brands Holdings Recent Developments and Future Plans
Figure 32. Procter & Gamble Recent Developments and Future Plans
Figure 34. Global Cold and Flu Drugs Revenue Share by Players in 2020
Figure 35. Cold and Flu Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Cold and Flu Drugs Revenue Market Share in 2020
Figure 37. Global Top 10 Players Cold and Flu Drugs Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Cold and Flu Drugs Revenue Share by Type in 2020
Figure 40. Global Cold and Flu Drugs Market Share Forecast by Type (2021-2026)
Figure 41. Global Cold and Flu Drugs Revenue Share by Application in 2020
Figure 42. Global Cold and Flu Drugs Market Share Forecast by Application (2021-2026)
Figure 43. North America Cold and Flu Drugs Sales Market Share by Type (2016-2026)
Figure 44. North America Cold and Flu Drugs Sales Market Share by Application (2016-2026)
Figure 45. North America Cold and Flu Drugs Revenue Market Share by Country (2016-2026)
Figure 46. United States Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Cold and Flu Drugs Sales Market Share by Type (2016-2026)
Figure 50. Europe Cold and Flu Drugs Sales Market Share by Application (2016-2026)
Figure 51. Europe Cold and Flu Drugs Revenue Market Share by Country (2016-2026)
Figure 52. Germany Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Cold and Flu Drugs Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Cold and Flu Drugs Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Cold and Flu Drugs Revenue Market Share by Region (2016-2026)
Figure 60. China Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Cold and Flu Drugs Sales Market Share by Type (2016-2026)
Figure 67. South America Cold and Flu Drugs Sales Market Share by Application (2016-2026)
Figure 68. South America Cold and Flu Drugs Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Cold and Flu Drugs Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Cold and Flu Drugs Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Cold and Flu Drugs Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Cold and Flu Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source